Moderna’s vaccine gets emergency use nod, India partner Cipla to import jabs3 min read . Updated: 30 Jun 2021, 12:10 AM IST
Moderna's covid-19 vaccine is the first foreign jab to get approval under the government’s revised norms for accelerated regulatory clearance of covid-19 jabs
Moderna Inc.’s covid-19 vaccine on Tuesday became the first messenger RNA jab and the fourth overall to be authorized for emergency use during the pandemic, with the Drugs Controller General of India granting its local partner Cipla Ltd an import licence.
Select your Category